NCT05244980View on ClinicalTrials.gov

A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA)

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

November 15, 2022

Study Completion Date

February 27, 2023

Conditions
Alopecia, Androgenetic
Interventions
DRUG

TDM-105795

TDM-105795 topical solution

DRUG

Placebo

Placebo for TDM-105795 topical solution

Trial Locations (2)

77845

J&S Studies, Inc., College Station

92123

TCR Medical Corporation, San Diego

All Listed Sponsors
collaborator

Therapeutics, Inc.

INDUSTRY

lead

Technoderma Medicines Inc.

INDUSTRY